Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
I Belinchón, R Rivera, C Blanch, M Comellas & L Lizán. (2016) Adherence, satisfaction and preferences for treatment in patients with psoriasis in the European Union: a systematic review of the literature. Patient Preference and Adherence 10, pages 2357-2367.
Read now
Read now
Enno Christophers, Siegfried Segaert, Gary Milligan, Charles T. Molta & Robert Boggs. (2013) Clinical improvement and satisfaction with biologic therapy in patients with severe plaque psoriasis: results of a European cross-sectional observational study. Journal of Dermatological Treatment 24:3, pages 193-198.
Read now
Read now
Else N. Kop, John E. M. Körver, Delphine Van Ruysevelt, Elke M. G. J. De Jong, Pieter G. Van der Valk & Peter C. M. Van de Kerkhof. (2009) Erythroderma in two patients with psoriasis upon discontinuation of efalizumab treatment. Journal of Dermatological Treatment 20:1, pages 67-69.
Read now
Read now
Articles from other publishers (20)
Hassan Dariushnejad, Leila Chodari, Mehrnoosh Sedighi, Soheila Akbari & Vajihe Ghorbanzadeh. (2022) Rheumatoid arthritis: current therapeutics compendium. Endocrine Regulations 56:2, pages 148-162.
Crossref
Crossref
Robert Gironés Petit, Amanda Cano, Alba Ortiz, Marta Espina, Josefina Prat, Montserrat Muñoz, Patrícia Severino, Eliana B. Souto, Maria L. García, Montserrat Pujol & Elena Sánchez-López. (2021) Psoriasis: From Pathogenesis to Pharmacological and Nano-Technological-Based Therapeutics. International Journal of Molecular Sciences 22:9, pages 4983.
Crossref
Crossref
Zhi-yin Xie, Yu Zhou, Sheng Deng, Wei Ding, Xing-wu Duan & Li-rong Yang. (2019) Effectiveness comparisons of acupuncture for psoriasis. Medicine 98:17, pages e15356.
Crossref
Crossref
Longjun Wang, Yun Tao, Sheng Deng, Liyuan Chu & Linge Li. (2019) Effectiveness comparisons of traditional Chinese medicine for psoriasis. Medicine 98:36, pages e17055.
Crossref
Crossref
Alexander Nast, Phyllis Spuls & Tamar Nijsten. 2014. Evidence-Based Dermatology. Evidence-Based Dermatology
175
199
.
U. Mrowietz, E.M.G.J. de Jong, K. Kragballe, R. Langley, A. Nast, L. Puig, K. Reich, J. Schmitt & R.B. Warren. (2013) A consensus report on appropriate treatment optimization and transitioning in the management of moderate‐to‐severe plaque psoriasis. Journal of the European Academy of Dermatology and Venereology 28:4, pages 438-453.
Crossref
Crossref
T.C. Lucka, D. Pathirana, A. Sammain, F. Bachmann, S. Rosumeck, R. Erdmann, J. Schmitt, H. Orawa, B. Rzany & A. Nast. (2012) Efficacy of systemic therapies for moderate-to-severe psoriasis: a systematic review and meta-analysis of long-term treatment. Journal of the European Academy of Dermatology and Venereology 26:11, pages 1331-1344.
Crossref
Crossref
Alexander Nast, Wolf-Henning Boehncke, Ulrich Mrowietz, Hans-Michael Ockenfels, Sandra Philipp, Kristian Reich, Thomas Rosenbach, Adel Sammain, Martin Schlaeger, Michael Sebastian, Wolfram Sterry, Volker Streit, Matthias Augustin, Ricardo Erdmann, Joachim Klaus, Joachim Koza, Siegrid Muller, Hans-Dieter Orzechowski, Stefanie Rosumeck, Gerhard Schmid-Ott, Tobias Weberschock & Berthold Rzany. (2012) S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 10, pages S1-s95.
Crossref
Crossref
P.P.M. van Lümig, R.J.B. Driessen, M.A.M. Berends, J.B.M. Boezeman, P.C.M. van de Kerkhof & E.M.G.J. de Jong. (2012) Safety of treatment with biologics for psoriasis in daily practice: 5-year data. Journal of the European Academy of Dermatology and Venereology 26:3, pages 283-291.
Crossref
Crossref
A. Nast, W. H. Boehncke, U. Mrowietz, H. M. Ockenfels, S. Philipp, K. Reich, T. Rosenbach, A. Sammain, M. Schlaeger, M. Sebastian, W. Sterry, V. Streit, M. Augustin, R. Erdmann, J. Klaus, J. Koza, S. Müller, H. D. Orzechowski, S. Rosumeck, G. Schmid-Ott, T. Weberschock & B. Rzany. (2012) German S3-guidelines on the treatment of psoriasis vulgaris (short version). Archives of Dermatological Research 304:2, pages 87-113.
Crossref
Crossref
Frank Bachmann, Georgios Kokolakis, Wolfram Sterry & Sandra Philipp. (2011) Etanercept overview of clinical experience in the treatment of psoriasis and psoriatic arthritis. International Journal of Clinical Rheumatology 6:2, pages 135-155.
Crossref
Crossref
. 2011. British Association of Dermatologists' Management Guidelines. British Association of Dermatologists' Management Guidelines
205
317
.
P.P.M. Van Lümig, L.L.A. Lecluse, R.J.B. Driessen, P.I. Spuls, J.B. Boezeman, P.C.M. Van De Kerkhof & E.M.G.J. De Jong. (2010) Switching from etanercept to adalimumab is effective and safe: results in 30 patients with psoriasis with primary failure, secondary failure or intolerance to etanercept. British Journal of Dermatology 163:4, pages 838-846.
Crossref
Crossref
C.H. Smith, A.V. Anstey, J.N.W.N. Barker, A.D. Burden, R.J.G. Chalmers, D.A. Chandler, A.Y. Finlay, C.E.M. Griffiths, K. Jackson, N.J. McHugh, K.E. McKenna, N.J. Reynolds & A.D. Ormerod. (2009) British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009. British Journal of Dermatology 161:5, pages 987-1019.
Crossref
Crossref
L. Puig, E. Roé, X. García-Navarro, F. Corella & A. Alomar. (2009) Efalizumab treatment of psoriasis vulgaris: a cohort study in outpatient clinical practice. Clinical and Experimental Dermatology 34:4, pages 469-475.
Crossref
Crossref
Sadia Ashraf-Benson, Geoffrey C Wall & Lisa A Veach. (2009) Serum Sickness–Like Reaction Associated with Efalizumab. Annals of Pharmacotherapy 43:2, pages 383-386.
Crossref
Crossref
A.K. Brimhall, L.N. King, J.C. Licciardone, H. Jacobe & A. Menter. (2008) Safety and efficacy of alefacept, efalizumab, etanercept and infliximab in treating moderate to severe plaque psoriasis: a meta-analysis of randomized controlled trials. British Journal of Dermatology 159:2, pages 274-285.
Crossref
Crossref
R.G. van Lingen, J.E.M. Körver, P.C.M. van de Kerkhof, M.A.M. Berends, D.W.A. van Rens, A.M. Langewouters, J.B.M. Boezeman, M.M.B. Seyger & E.M.G.J. de Jong. (2008) Relevance of compartmentalization of T-cell subsets for clinical improvement in psoriasis: effect of immune-targeted antipsoriatic therapies. British Journal of Dermatology 159:1, pages 91-96.
Crossref
Crossref
R.J.B. Driessen, M.A.M. Berends, J.B. Boezeman, P.C.M. van de Kerkhof & E.M.G.J. de Jong. (2008) Psoriasis treatment with etanercept and efalizumab: clinical strategies influencing treatment outcome. British Journal of Dermatology 158:5, pages 1098-1106.
Crossref
Crossref
. (2007) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 16:12.
Crossref
Crossref